Developer of advanced, controlled release drug delivery products which administer drugs through the skin, by oral delivery to the gastrointestinal tract, through tissues in the oral cavity, and by other means. Products provide significant advantages over existing controlled release drug delivery products and conventional oral, injectable, and continuous infusion methods by increasing efficacy, safety, bioavailability, and patient compliance and comfort. Research and development are focused on design and development of improved delivery systems for off-patent and proprietary drugs, thus avoiding much of the risk and expense associated with new drug discovery.
Missing: Theratech's Product Demo & Case Studies
Promote your product offering to tech buyers.
Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.
Missing: Theratech's Product & Differentiators
Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).
Theratech Frequently Asked Questions (FAQ)
When was Theratech founded?
Theratech was founded in 1985.
Where is Theratech's headquarters?
Theratech's headquarters is located at 417 Wakara Way, Salt Lake City.
What is Theratech's latest funding round?
Theratech's latest funding round is PIPE.
Who are the investors of Theratech?
Investors of Theratech include SR One.
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.